Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) currently has a daily average trading volume of 1.86M but it saw 1820876 shares traded in last market. With a market cap of 11.31B USD, the company’s current market price of $13.58 came rising about 1.04 while comparing to the previous closing price of $13.44. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.89 and as low as $12.50. In the recent trading on the day, stock has struck highest price mark of $13.51 while lowest mark touched by it was $13.61.
Taking a look at 20-day trading activity of Dr. Reddy’s Laboratories Ltd. ADR (RDY) gives us an average price of $13.00, while its current price level is -19.61% below from 52-week high level whereas it is 8.64% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $13.75 while that of 200 days or SMA-200 reads an average of $14.99. A closer look into the stock’s movement over the week reveals that its volatility is standing at 0.81% during that period while stretching the period over a month that increases to 1.25%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 58.61 which implies that the stock is in neutral territory.
Over the week, RDY’s stock price is moving 7.18% up while it is 1.57% when we observe its performance for the past one month. Year-to-date it is -14.00% down and over the past year, the stock is showing a downside performance of -10.05%.
The company is expected to be releasing its next quarterly report on 2025-Jan-22, for which analysts forecasted an EPS of 16.89 while estimate for next year EPS is 68.82. In next quarter, company is expected to be making quarterly sales of $88.32B as analysts are expecting the sales for current fiscal year at $323.16B and seeing the company making $352.03B in sales next year. Moreover, analysts are in estimates of $83.23B for current-quarter revenue.
Currently, Dr. Reddy’s Laboratories Ltd. ADR’s total number of outstanding shares is 834.42M with 0.00% of that held by the insiders while 15.04% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 16.88% and return on equity (ROE) at 18.51%. It has a price to earnings ratio (P/E ratio) of 17.66 while having a 16.91 of forward P/E ratio. Stock’s beta reads 0.51. Stock has a price to book (P/B) ratio of 3.05 while price to sale or P/S ratio amounts to 3.04. Its return on asset (ROA) is 12.70% on average.
